Cargando…
Reversible blindness after erroneous prescription of closantel: A case report
A 20‐year‐old girl was referred with vision loss upon closantel use. Plasma exchange and high‐dose corticosteroid pulse therapy were administered. A 2.5‐year follow‐up showed improved vision and increased layer thickness of the peripheral nerve fiber. Early treatment with plasma exchange and high‐do...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8659543/ https://www.ncbi.nlm.nih.gov/pubmed/34938546 http://dx.doi.org/10.1002/ccr3.5157 |
_version_ | 1784612987963703296 |
---|---|
author | Cheraghmakani, Hamed Jafari, Reza Karimpour‐razkenari, Elahe Ghazaeian, Monireh |
author_facet | Cheraghmakani, Hamed Jafari, Reza Karimpour‐razkenari, Elahe Ghazaeian, Monireh |
author_sort | Cheraghmakani, Hamed |
collection | PubMed |
description | A 20‐year‐old girl was referred with vision loss upon closantel use. Plasma exchange and high‐dose corticosteroid pulse therapy were administered. A 2.5‐year follow‐up showed improved vision and increased layer thickness of the peripheral nerve fiber. Early treatment with plasma exchange and high‐dose corticosteroid therapy can be beneficial to reverse closantel toxicity. |
format | Online Article Text |
id | pubmed-8659543 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-86595432021-12-21 Reversible blindness after erroneous prescription of closantel: A case report Cheraghmakani, Hamed Jafari, Reza Karimpour‐razkenari, Elahe Ghazaeian, Monireh Clin Case Rep Case Report A 20‐year‐old girl was referred with vision loss upon closantel use. Plasma exchange and high‐dose corticosteroid pulse therapy were administered. A 2.5‐year follow‐up showed improved vision and increased layer thickness of the peripheral nerve fiber. Early treatment with plasma exchange and high‐dose corticosteroid therapy can be beneficial to reverse closantel toxicity. John Wiley and Sons Inc. 2021-12-09 /pmc/articles/PMC8659543/ /pubmed/34938546 http://dx.doi.org/10.1002/ccr3.5157 Text en © 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Case Report Cheraghmakani, Hamed Jafari, Reza Karimpour‐razkenari, Elahe Ghazaeian, Monireh Reversible blindness after erroneous prescription of closantel: A case report |
title | Reversible blindness after erroneous prescription of closantel: A case report |
title_full | Reversible blindness after erroneous prescription of closantel: A case report |
title_fullStr | Reversible blindness after erroneous prescription of closantel: A case report |
title_full_unstemmed | Reversible blindness after erroneous prescription of closantel: A case report |
title_short | Reversible blindness after erroneous prescription of closantel: A case report |
title_sort | reversible blindness after erroneous prescription of closantel: a case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8659543/ https://www.ncbi.nlm.nih.gov/pubmed/34938546 http://dx.doi.org/10.1002/ccr3.5157 |
work_keys_str_mv | AT cheraghmakanihamed reversibleblindnessaftererroneousprescriptionofclosantelacasereport AT jafarireza reversibleblindnessaftererroneousprescriptionofclosantelacasereport AT karimpourrazkenarielahe reversibleblindnessaftererroneousprescriptionofclosantelacasereport AT ghazaeianmonireh reversibleblindnessaftererroneousprescriptionofclosantelacasereport |